Attachment #1 - CMS-10549.60-day FRN (82 FR 49816)-10-27-17

49816

Federal Register / Vol. 82, No. 207 / Friday, October 27, 2017 / Notices

must be received not later than
November 13, 2017.
A. Federal Reserve Bank of Atlanta
(Kathryn Haney, Director of
Applications) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
[email protected]:
1. Lawrence Andrew Proffitt,
Gatlinburg, Tennessee; to act as trustee
and thereby vote the shares of
Tennessee State Bancshares, Inc., and
thereby indirectly vote the shares of
Tennessee State Bank, both of Pigeon
Forge, Tennessee.
Board of Governors of the Federal Reserve
System, October 23, 2017.
Ann Misback,
Secretary of the Board.
BILLING CODE 6210–01–P

asabaliauskas on DSKBBXCHB2PROD with NOTICES

BILLING CODE P

[Document Identifier: CMS–10518 and CMS–
10549]

Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than
November 15, 2017.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. The Martin Grandchildren’s Trust
dated 5.24.17, with William C. Martin
and Sally A. Martin as co-trustees; the
William C. Martin 2016 Grantor
Retained Annuity Trust dated 1.27.16,
with William C. Martin as trustee; the
William C. Martin 2017 Grantor
Retained Annuity Trust dated 5.31.17,
with William C. Martin as trustee; the
William C. Martin GRAT Remainder
Trust fbo William S. Martin dated
1.27.16, with William C. Martin as
trustee; the William C. Martin GRAT
Remainder Trust fbo Michael C. Martin
dated 1.27.16, with William C. Martin as
trustee; Keweenaw, L.L.C., with William

Jkt 244001

[FR Doc. 2017–23429 Filed 10–26–17; 8:45 am]

Centers for Medicare & Medicaid
Services

FEDERAL RESERVE SYSTEM

18:41 Oct 26, 2017

Board of Governors of the Federal Reserve
System, October 24, 2017.
Ann Misback,
Secretary of the Board.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2017–23357 Filed 10–26–17; 8:45 am]

VerDate Sep<11>2014

C. Martin as manager; Sally A. Martin,
individually; William S. Martin,
individually; and Michael C. Martin,
individually, all of Ann Arbor,
Michigan; to join William C. Martin as
members of the Martin Family Control
Group and retain voting shares of Arbor
Bancorp, Inc., and thereby indirectly
retain voting shares of Bank of Ann
Arbor, both of Ann Arbor, Michigan.

Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:

The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 26, 2017.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
SUMMARY:

PO 00000

Frm 00036

Fmt 4703

Sfmt 4703

recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to http://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
http://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
[email protected].
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10518 Application for
Participation in the Intravenous
Immune Globulin (IVIG)
Demonstration
CMS–10549 Generic Clearance for
Questionnaire Testing and
Methodological Research for the
Medicare Current Beneficiary
Survey (MCBS)
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register

E:\FR\FM\27OCN1.SGM

27OCN1

Federal Register / Vol. 82, No. 207 / Friday, October 27, 2017 / Notices
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Application for
Participation in the Intravenous
Immune Globulin (IVIG) Demonstration;
Use: Traditional fee-for-service (FFS)
Medicare covers some or all
components of home infusion services
depending on the circumstances. By
special statutory provision, Medicare
Part B covers intravenous immune
globulin (IVIG) for persons with primary
immune deficiency disease (PIDD) who
wish to receive the drug at home.
However, Medicare does not separately
pay for any services or supplies to
administer it if the person is not
homebound and otherwise receiving
services under a Medicare Home Health
episode of care. As a result, many
beneficiaries have chosen to receive the
drug at their doctor’s office or in an
outpatient hospital setting.
On September 29, 2017, the ‘‘Disaster
Tax Relief and Airport and Airway
Extension Act of 2017’’ was enacted into
law. Section 302 of this legislation
extends the Medicare IVIG
Demonstration through December 31,
2020. While existing beneficiaries
enrolled in the demonstration as of
September 30, 2017 will be
automatically re-enrolled, in order to
continue to enroll new beneficiaries into
the demonstration, an application is
required. The original enrollment and
financial limits remain and CMS will
continue to monitor both to assure that
statutory limitations are not exceeded.
This collection of information is for
the application to participate in the
demonstration. Participation is
voluntary and may be terminated by the
beneficiary at any time. Beneficiaries
who do not participate will continue to
be eligible to receive all of the regular
Medicare Part B benefits that they are
would be eligible for in the absence of
the demonstration. Form Number:
CMS–10518 (OMB control number:
0938–1246); Frequency: Annually;
Affected Public: Individuals and
households; Number of Respondents:
1,220; Total Annual Responses: 1,220
Total Annual Hours: 305. (For policy
questions regarding this collection
contact Jody Blatt at 410–786–6921.)

VerDate Sep<11>2014

17:54 Oct 26, 2017

Jkt 244001

2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Generic
Clearance for Questionnaire Testing and
Methodological Research for the
Medicare Current Beneficiary Survey
(MCBS); Use: The purpose of this OMB
clearance package is to extend the
approval of the generic clearance to
support an effort to evaluate the
operations and content of the Medicare
Current Beneficiary Survey (MCBS). The
MCBS is a continuous, multipurpose
survey of a nationally representative
sample of aged, disabled, and
institutionalized Medicare beneficiaries.
The MCBS, which is sponsored by the
Centers for Medicare & Medicaid
Services (CMS), is the only
comprehensive source of information on
the health status, health care use and
expenditures, health insurance
coverage, and socioeconomic and
demographic characteristics of the
entire spectrum of Medicare
beneficiaries. The core of the MCBS is
a series of interviews with a stratified
random sample of the Medicare
population, including aged and disabled
enrollees, residing in the community or
in institutions. Questions are asked
about enrollees’ patterns of health care
use, charges, insurance coverage, and
payments over time. Respondents are
asked about their sources of health care
coverage and payment, their
demographic characteristics, their
health and work history, and their
family living circumstances. In addition
to collecting information through the
core questionnaire, the MCBS collects
information on special topics. Form
Number: CMS–10549 (OMB control
number 0938–1275); Frequency:
Occasionally; Affected Public:
Individuals or Households; Number of
Respondents: 1,500; Total Annual
Responses: 1,500; Total Annual Hours:
1,117. (For policy questions regarding
this collection contact William Long at
410–786–7927.)
Dated: October 24, 2017.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2017–23451 Filed 10–26–17; 8:45 am]
BILLING CODE 4120–01–P

PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

49817

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3336–FN]

Medicare and Medicaid Programs:
Approval of an Application From the
Joint Commission (TJC) for Continued
CMS Approval of Its Critical Access
Hospital (CAH) Accreditation Program
Centers for Medicare and
Medicaid Services, HHS.
ACTION: Final notice.
AGENCY:

This final notice announces
our decision to approve the Joint
Commission (TJC) for continued
recognition as a national accrediting
organization for critical access hospitals
(CAHs) that wish to participate in the
Medicare or Medicaid programs.
DATES: This final notice is effective
November 21, 2017 through November
21, 2023.
FOR FURTHER INFORMATION CONTACT:
Monda Shaver, (410) 786–3410, Karena
Meushaw, (410) 786–6609 or Patricia
Chmielewski, (410) 786–6899.
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Background
Under the Medicare program eligible
beneficiaries may receive covered
services in a critical access hospital
(CAH), provided certain requirements
are met. Sections 1820(c)(2)(B) and
1861(mm) of the Social Security Act
(the Act) establish distinct criteria for
facilities seeking designation as a CAH.
The minimum requirements that a CAH
must meet to participate in the Medicare
Program are at 42 CFR part 485, subpart
F. Conditions for Medicare payment for
CAHs are at 42 CFR 413.70. Applicable
regulations concerning provider
agreements are at 42 CFR part 489 and
those pertaining to facility survey and
certification are at 42 CFR part 488,
subparts A and B.
For a CAH to enter into a provider
agreement with the Medicare program, a
CAH must first be certified by a State
survey agency as complying with the
conditions or requirements set forth in
section 1820 of the Act and our
regulations at part 485. Subsequently,
the CAH is subject to ongoing review by
a State survey agency to determine
whether it continues to meet the
Medicare requirements. However, there
is an alternative to State compliance
surveys. Certification by a nationally
recognized accreditation program can
substitute for ongoing State review.
Section 1865(a)(1) of the Act provides
that if the Secretary of the Department

E:\FR\FM\27OCN1.SGM

27OCN1